Suven Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

568.65

617.20

755.43

564.79

475.62

Operating profit

267.24

261.38

343.60

236.39

210.60

Interest

1.65

1.72

2.93

3.30

6.47

Gross profit

289.85

280.95

484.34

277.21

210.23

EPS (Rs)

7.82

7.58

14.20

7.72

11.51

Other income

24.26

21.29

143.67

44.12

6.10

Stock adjustment

30.47

-15.31

-18.98

-41.37

1.19

Raw material

124.57

196.63

248.76

210.70

143.18

Power and fuel

-

-

-

-

-

Employee expenses

52.78

50.68

56.13

44.35

38.37

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

4.31

4.33

-

6.89

Expenses capitalised

-

-

-

-

-

Other expenses

93.58

119.51

121.59

114.72

75.38

Provisions made

-

-

-

-

-

Depreciation

21.63

21.30

20.93

18.17

14.56

Taxation

69.20

66.67

101.95

62.40

49.10

Net profit / loss

199.02

192.97

361.46

196.64

146.56

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

25.46

25.46

25.46

25.46

12.73

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

47.00

42.35

45.48

41.85

44.28

GPM (%)

48.89

44.00

53.87

45.53

43.64

NPM (%)

33.57

30.22

40.20

32.29

30.42